ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Hsbc Korea Etf

Hsbc Korea Etf (HKOR)

3,427.00
77.00
(2.30%)
Closed January 05 11:30AM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
3,427.00
Bid
3,423.00
Ask
3,431.00
Volume
611
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
Previous Close
3,350.00
Open
-
Last Trade
2
@
3427
(O)
Last Trade Time
Financial Volume
20,944p
VWAP
3,427.83
Average Volume (3m)
-
Shares Outstanding
19,262,728,000
Dividend Yield
-
PE Ratio
28.14
Earnings Per Share (EPS)
1.22
Revenue
65.91B
Net Profit
23.53B

About Hsbc Korea Etf

Sector
Offices-bank Holding Company
Industry
Offices-bank Holding Company
Website
Headquarters
London, Gbr
Founded
-
Hsbc Korea Etf is listed in the Offices-bank Holding Company sector of the London Stock Exchange with ticker HKOR. The last closing price for Hsbc Korea Etf was 3,350p. Over the last year, Hsbc Korea Etf shares have traded in a share price range of 0.00p to 0.00p.

Hsbc Korea Etf currently has 19,262,728,000 shares outstanding. The market capitalization of Hsbc Korea Etf is £645.30 billion. Hsbc Korea Etf has a price to earnings ratio (PE ratio) of 28.14.

HKOR Latest News

HSBC ETFs MSCI Korea Capped ETF $ Net Asset Value(s)

HSBC ETFs MSCI Korea Capped ETF $ 24 January 2024 Fund: HSBC MCSI KOREA Share Redeemed CAPPED UCITS Valuation Shares since Previous NET Asset NAV per Ex Dividend ETF Date ISIN Code in Issue...

HSBC ETFs MSCI Korea Capped ETF $ Net Asset Value(s)

HSBC ETFs MSCI Korea Capped ETF $ 23 January 2024 Fund: HSBC MCSI KOREA Share Redeemed CAPPED UCITS Valuation Shares since Previous NET Asset NAV per Ex Dividend ETF Date ISIN Code in Issue...

HSBC ETFs MSCI Korea Capped ETF $ Net Asset Value(s)

HSBC ETFs MSCI Korea Capped ETF $ 22 January 2024 Fund: HSBC MCSI KOREA Share Redeemed CAPPED UCITS Valuation Shares since Previous NET Asset NAV per Ex Dividend ETF Date ISIN Code in Issue...

HSBC ETFs MSCI Korea Capped ETF $ Net Asset Value(s)

HSBC ETFs MSCI Korea Capped ETF $ 19 January 2024 Fund: HSBC MCSI KOREA Share Redeemed CAPPED UCITS Valuation Shares since Previous NET Asset NAV per Ex Dividend ETF Date ISIN Code in Issue...

HSBC ETFs MSCI Korea Capped ETF $ Net Asset Value(s)

HSBC ETFs MSCI Korea Capped ETF $ 18 January 2024 Fund: HSBC MCSI KOREA Share Redeemed CAPPED UCITS Valuation Shares since Previous NET Asset NAV per Ex Dividend ETF Date ISIN Code in Issue...

HSBC ETFs MSCI Korea Capped ETF $ Net Asset Value(s)

HSBC ETFs MSCI Korea Capped ETF $ 17 January 2024 Fund: HSBC MCSI Share KOREA Redeemed CAPPED since NAV Ex UCITS Valuation Shares Previous NET Asset per Dividend ETF Date ISIN Code in Issue...

HSBC ETFs MSCI Korea Capped ETF $ Net Asset Value(s)

HSBC ETFs MSCI Korea Capped ETF $ 16 January 2024 Fund: HSBC MCSI KOREA Share Redeemed CAPPED UCITS Valuation Shares since Previous NET Asset NAV per Ex Dividend ETF Date ISIN Code in Issue...

HSBC ETFs MSCI Korea Capped ETF $ Net Asset Value(s)

HSBC ETFs MSCI Korea Capped ETF $ 15 January 2024 Fund: HSBC MCSI KOREA Share Redeemed CAPPED UCITS Valuation Shares since Previous NET Asset NAV per Ex Dividend ETF Date ISIN Code in Issue...

HSBC ETFs MSCI Korea Capped ETF $ Net Asset Value(s)

HSBC ETFs MSCI Korea Capped ETF $ 12 January 2024 Fund: HSBC MCSI KOREA Share Redeemed CAPPED UCITS Valuation Shares since Previous NET Asset NAV per Ex Dividend ETF Date ISIN Code in Issue...

HSBC ETFs MSCI Korea Capped ETF $ Net Asset Value(s)

HSBC ETFs MSCI Korea Capped ETF $ 11 January 2024 Fund: HSBC MCSI KOREA Share Redeemed CAPPED UCITS Valuation Shares since Previous NET Asset NAV per Ex Dividend ETF Date ISIN Code in Issue...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000SP
40000000SP
120000000SP
260000000SP
520000000SP
1560000000SP
2600000000SP

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
FCUVFocus Universal Inc
$ 0.9499
(174.93%)
260.93M
NITON2OFF Inc
$ 2.6306
(145.85%)
358.28M
CRNCCerence Inc
$ 19.33
(143.76%)
161.8M
KITTNauticus Robotics Inc
$ 3.8249
(140.56%)
104.8M
ACONAclarion Inc
$ 0.2984
(110.14%)
305.64M
HWHHWH International Inc
$ 0.4621
(-28.80%)
7.08M
SMSTDefiance Daily Target 2x Short MSTR ETF
$ 5.69
(-26.30%)
24.62M
RAINRain Enhancement Technologies Holdco Inc
$ 5.59
(-23.42%)
155.16k
PTLEPTL Ltd
$ 9.35
(-23.30%)
967.95k
NXUNXU Inc
$ 0.725868
(-22.78%)
7.4M
NITON2OFF Inc
$ 2.6306
(145.85%)
358.28M
TGLTreasure Global Inc
$ 0.382
(101.58%)
337.5M
ACONAclarion Inc
$ 0.2984
(110.14%)
305.64M
FCUVFocus Universal Inc
$ 0.9499
(174.93%)
260.93M
NVDANVIDIA Corporation
$ 144.47
(4.45%)
230.01M

Discussion

View Full Feed
sand sand 6 minutes ago
Thank you Ducci for all your sharing and insights extremely helpful. I'm slowly diligently getting there rewiring the brain and focusing on what shows the moves. Much continued success this week. Thank you again.
SPY
mining101 mining101 6 minutes ago
Moving hard soon 
EFSH
mining101 mining101 7 minutes ago
Superb
MEGL
benz280c benz280c 14 minutes ago
Speak louder and maybe you will convince somebody that this is how you really feel. No need to be insecure around your fellow investors.
GDVM
rx7171 rx7171 21 minutes ago
In addition MABs are approved for only a limited portion of the AD population, whereas Blarcamasine appears to be effective in 70-80% of the ITT population with its strongest efficacy in the 70% with wild type Sigma-1.
AVXL
TheHound TheHound 22 minutes ago
Learn how to use the bull market support band with that chart and you’ll have a powerful tool under your belt!
XRPUSD
Investor2014 Investor2014 25 minutes ago
When I say that the totality of information is what Anavex rely on it does take into account the pretty ineffective SOC, associated risks and inconveniences for patients.

Still any drug regulatory process must and should look carefully at the data to ensure that neither type one or tw
AVXL
nowwhat2 nowwhat2 30 minutes ago
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
BTCUSD
rx7171 rx7171 31 minutes ago
Yes that spike to $23 in June of 2021 was driven entirely by the excellent Phase II data for PDD.

Yet now after completing the AD 2b/3 trial and having an EMA MAA accepted for evaluation the share price is barely half that number!

I understand the company being very ca
PDD
sunspotter sunspotter 36 minutes ago
Black Cat Moan was one of my favorites back in the day:

https://youtu.be/cxN-frB1UbI?si=Ph6XMC3omR0rRlmR

Edit: auto correct changed Moan to Moana. The cultural prevalence of Disney.
Investor2014 Investor2014 38 minutes ago
The ex-biotech executive is back in the Rett trap posting mode - hope it goes better with the biased approach this time.

Listing all the site PI’s is not world class peer review WGT confirmation.
AVXL
nowwhat2 nowwhat2 39 minutes ago
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
sunspotter sunspotter 41 minutes ago
I rather think you missed the point. It’s not that higher doses of GALT’s drug are toxic, it’s that they are ineffective.

Given the purported mechanism, that almost certainly means lower doses are too, and that the implication that the lower dose worked is merely an artefact.
GALT
nowwhat2 nowwhat2 44 minutes ago
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
XRPUSD
CrossFireTrader CrossFireTrader 47 minutes ago
I try to avoid Krispy Kreme's af all costs. Thanks for your insight...
GDVM
skitahoe skitahoe 47 minutes ago
Dstock, you may be very right about the data from compassionate use being included, but if it is, I would think that the protocols used on every one of those patients would need to be included as none are specifically on the trial protocol. It's essentially anecdotal evidence, but it could all add
NWBO
Pickme2 Pickme2 48 minutes ago
Stop wasting our time with your ongoing Manipulated nonsense.... Just read the S-1 
Filed with the sec.... 


ATMH
georgejjl georgejjl 50 minutes ago
The MABs are no where near being the standard of care for treating Alzheimer’s patients.
AVXL
benz280c benz280c 51 minutes ago
Phone died when responding to that. In summary, I think the 24/7 is multi-pronged. It is necessary for the kind of business that Veemost is and will be, which aligns it and will help it qualify for Gold. I do not recall it expressly said that Gold was reached and turned down. Not saying that didn't
GDVM
Sheepdog Sheepdog 1 hour ago
Really? So you think the SEC is going to start arresting OTC Scammers and Pump/Dumpers? I hope so...about time.
GCAN
Hummingbird2 Hummingbird2 1 hour ago
$GTII ~ Just listen in the first 5 mins about $GTII 🛫 after March? https://www.youtube.com/watch?v=Ag2f2rDlq5g
GTII
Jane1999 Jane1999 1 hour ago
Here the CEO : https://www.wsj.com/market-data/quotes/CA/XCNQ/TWOH/company-people/executive-profile/149699
TWOH
Curious Bystander Curious Bystander 1 hour ago
The Expert Market was set up by the SEC for several very specific reasons. But you could generally say that a security lands in that market when a company is either UNABLE or UNWILLING to file certain SEC-required forms.

UNABLE or UNWILLING. Hmmmm…..I wonder which category Quantum
FLCX

Your Recent History

Delayed Upgrade Clock